SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNostra Terra Regulatory News (NTOG)

  • There is currently no data for NTOG

Dallas Operations Office

21 Dec 2018 07:00

RNS Number : 1486L
Nostra Terra Oil & Gas Company PLC
21 December 2018
 

21 December 2018

 

Nostra Terra Oil and Gas Company plc

("Nostra Terra" or the "Company")

 

Nostra Terra opens Dallas Operations Office

 

Nostra Terra (AIM:NTOG), the oil and gas exploration and production company with a portfolio of assets in the USA and Egypt, is pleased to announce that the Company has opened a new permanent operations office in Dallas, Texas.

 

Since 2016, as Nostra Terra has grown its portfolio of producing oil assets in Texas, the Company has outsourced many operational and business development functions. This flexible approach has enabled Nostra Terra to manage its costs, as the Company grew.

 

However, with the acquisition and development of the Mesquite Prospect, Nostra Terra anticipates a significant increase in its operating activity in the Permian Basin during 2019. As such, the Company is increasing its in-house operational capabilities, both to support better management of its producing oil assets and to assess new acquisition opportunities.

 

Matt Lofgran, Chief Executive Officer of Nostra Terra, commented:

 

"As we enter 2019, Nostra Terra is well positioned to execute the next phase of its growth strategy. We expect to receive the engineered economics report of the Mesquite Field Development Plan by mid January. Assuming this is in line with our expectations, it is important that we prepare the Company to move quickly to take advantage of this. There is a great deal of regional competitive interest in opening new plays in the Permian Basin, so now is the right time to increase our in-house capabilities."

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

For further information, visit www.ntog.co.uk or contact:

 

Nostra Terra Oil and Gas Company plc

Matt Lofgran, CEO

 

Tel:

+1 480 993 8933

Strand Hanson Limited

(Nominated & Financial Adviser and Joint Broker)

Rory Murphy / Ritchie Balmer / Jack Botros

 

Tel:

+44 (0) 20 7409 3494

Smaller Company Capital Limited (Joint Broker)

Rupert Williams / Jeremy Woodgate

Tel:

+44 (0) 20 3651 2910

 

About the Mesquite Prospect

 

The Mesquite Prospect is in West Texas and covers 1,384 net acres in the prolific Permian Basin. The Mesquite Prospect is proven to produce from multiple, stacked-pay reservoirs. Nostra Terra has identified 8 targets to drill horizontal wells across the Mesquite leases.

 

The target formations at the Mesquite Prospect are "tight", meaning the oil-bearing rock formations are of low permeability. As such, the target formations have characteristics that make them ideal targets for horizontal drilling and have delivered substantial oil production in other areas of the Permian Basin. Comparable regional horizontal drilling has delivered initial oil production rates of 200-300bopd per well.

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFESFESFASEDE
Date   Source Headline
26th Jun 20257:00 amRNSChange of Name
20th Jun 202510:40 amRNSResults of Annual General Meeting
3rd Jun 20257:00 amRNS-REngage Investor Presentation
23rd May 20257:00 amRNS2024 Audited Annual Results & Notice of AGM
3rd Apr 20257:00 amRNSPartner Approval for Fouke 3 Well
17th Mar 20257:00 amRNS-REngage Investor Presentation
11th Mar 20257:00 amRNSHolding(s) in Company
4th Mar 20257:00 amRNSCompletion of £500,000 Fundraise
24th Feb 20257:00 amRNSProduction and Operations Update
11th Feb 202512:57 pmRNSHolding(s) in Company
29th Jan 20257:00 amRNS3-Year Renewal of Senior Lending Facility
23rd Jan 20257:00 amRNSHolding(s) in Company
21st Jan 202512:29 pmRNSHolding(s) in Company
21st Jan 20257:05 amRNSIncreased Holdings in the Company
21st Jan 20257:00 amRNSProduction and Operations Update
2nd Jan 20257:00 amRNSBoard Change
27th Dec 20244:35 pmRNSHolding(s) in Company
27th Dec 20247:00 amRNSHolding(s) in Company
28th Nov 202412:15 pmRNSHolding(s) in Company
21st Nov 20247:00 amRNSFundraise to increase production & cash flow
12th Nov 20244:48 pmRNSHolding(s) in Company
11th Nov 20247:00 amRNSProduction and Operations Update
20th Sep 202411:50 amRNSShare Issuance
20th Sep 20247:00 amRNSShare Issuance
19th Sep 20247:00 amRNSInterim Results for six months ended 30 June 2024
6th Sep 20247:00 amRNSChange of Nominated Adviser
29th Aug 202412:30 pmRNSHolding(s) in Company
27th Aug 202412:41 pmRNSHolding(s) in Company
22nd Aug 20244:54 pmRNSHolding(s) in Company
20th Aug 202412:15 pmRNSHolding(s) in Company
19th Aug 20243:52 pmRNSHolding(s) in Company
16th Aug 20244:45 pmRNSHolding(s) in Company
16th Aug 20247:00 amRNSHolding(s) in Company
14th Aug 20244:56 pmRNSHolding(s) in Company
13th Aug 20247:00 amRNSHolding(s) in Company
7th Aug 202411:52 amRNSHolding(s) in Company
2nd Aug 20244:28 pmRNSDirector Increases Participation in Fundraise
29th Jul 20247:00 amRNS£450,000 Fundraise aimed at increasing production
17th Jul 202411:08 amRNSAdvisor Change
17th Jul 202410:13 amRNSResult of Meeting
1st Jul 20245:00 pmRNSCorporate Update & Notice of General Meeting
27th Jun 20242:46 pmRNSResult of AGM
27th Jun 20247:00 amRNSAppointment of Non-Executive Director
13th Jun 20247:00 amRNSProposed Appointment of Non-Executive Director
31st May 20247:00 amRNSFinal Results
20th May 20248:01 amRNSBoard Changes
22nd Feb 20247:00 amRNSHolding(s) in Company
6th Feb 20249:23 amRNSHolding(s) in Company
30th Jan 20249:37 amRNSHolding(s) in Company
30th Jan 20249:34 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.